Eprontia

Drug Azurity Pharmaceuticals, Inc.
Total Payments
$14,884
Transactions
786
Doctors
638
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2023 $6,032 251 202
2022 $8,852 535 481

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $13,984 785 94.0%
Consulting Fee $900.00 1 6.0%

Top Doctors Receiving Payments for Eprontia — Page 26

Doctor Specialty Location Total Records
, P.A.-C Physician Assistant Mesa, AZ $12.01 1
, M.D Internal Medicine San Tan Valley, AZ $12.01 1
, D.D.S General Practice Scottsdale, AZ $12.00 1
, MD Neurology with Special Qualifications in Child Neurology Leesburg, FL $12.00 1
, DDS Dentist Scottsdale, AZ $12.00 1
, D.O Neurology Coral Springs, FL $11.85 1
, FNP-C Family Sandy, UT $11.81 1
, PAC Physician Assistant Salt Lake City, UT $11.81 1
, MD Family Medicine Salt Lake City, UT $11.81 1
, M.D Pediatrics Des Moines, IA $11.78 1
, NP-C Family Cincinnati, OH $11.71 1
, NP Family Cincinnati, OH $11.71 1
, M.D Pain Medicine Cincinnati, OH $11.71 1

About Eprontia

Eprontia is a drug associated with $14,884 in payments to 638 healthcare providers, recorded across 786 transactions in the CMS Open Payments database. The primary manufacturer is Azurity Pharmaceuticals, Inc..

Payment data is available from 2022 to 2023. In 2023, $6,032 was paid across 251 transactions to 202 doctors.

The most common payment nature for Eprontia is "Food and Beverage" ($13,984, 94.0% of total).